CClinicalTrials.gg
CompletedNCT07730398Updated Jul 28, 2026

Optimizing Noisy Galvanic Vestibular Stimulation Frequency Range for Enhancing Vestibular Perception and Manual Control Performance

An interventional study of Low-frequency noisy galvanic vestibular stimulation (nGVS) and High-frequency noisy galvanic vestibular stimulation (nGVS) in Vestibular Function Tests and Sensorimotor Performance, sponsored by National Aeronautics and Space Administration (NASA). Completed at 1 site in United States. Open to participants aged 22 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-07-28.

Sponsored by National Aeronautics and Space Administration (NASA) · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 2 years 4 months after the study started (first participant enrolled Feb 2024, registered Jul 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
18
Allocation
Randomized
Ages
22 Years and older
Sex
All
01

Study summary

This randomized crossover interventional study evaluated the effects of different frequency ranges of noisy galvanic vestibular stimulation (nGVS) on vestibular perception, perceptual motion tracking, and manual control performance in healthy adults. Each participant completed three experimental conditions in randomized order: no stimulation (control), low-frequency nGVS, and high-frequency nGVS. Vestibular perceptual thresholds, perceptual tracking, and manual control performance were assessed during each condition to determine whether stimulation frequency influenced sensorimotor function.

Read the detailed description

The purpose of this study was to investigate whether the frequency content of noisy galvanic vestibular stimulation influences vestibular perceptual sensitivity, tracking accuracy, and manual control performance. Healthy adult participants completed a randomized crossover protocol in which they received no stimulation, low-frequency nGVS, and high-frequency nGVS during separate experimental conditions within a single study session. Outcome measures included vestibular perceptual thresholds, tracking error rate, and measures of manual control performance. The results were intended to improve understanding of vestibular neuromodulation and inform optimization of nGVS parameters for future aerospace and clinical applications.

02

Conditions studied

  • Vestibular Function Tests
  • Sensorimotor Performance
03

In context

Lead sponsor

National Aeronautics and Space Administration (NASA) is the lead sponsor of 12 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
22 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Subjects were required to pass a physical exam adminisitrated by NASA JSC Clinic.

Exclusion criteria

Exclusion Criteria:

  • No history of neurologic, vestibular, or autonomic disease.
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
18 participants (actual)

Study arms

  • No intervention
    Control - No noisy galvanic vestibular stimulation

    Participants completed testing without noisy galvanic vestibular stimulation.

  • Experimental
    Low-frequency noisy galvanic vestibular stimulation

    Participants received low-frequency noisy galvanic vestibular stimulation during testing. Low frequency was 0-2 Hz.

    Device: Low-frequency noisy galvanic vestibular stimulation (nGVS)

  • Experimental
    High-frequency noisy galvanic vestibular stimulation

    Participants received high-frequency noisy galvanic vestibular stimulation during testing. High-frequency was 10-30 Hz.

    Device: High-frequency noisy galvanic vestibular stimulation (nGVS)

Interventions

  • DeviceLow-frequency noisy galvanic vestibular stimulation (nGVS)

    Participants received low-frequency noisy galvanic vestibular stimulation through electrodes placed over the bilateral mastoid processes during experimental testing. Stimulation parameters were consistent with the approved study protocol. Frequency was 0-2Hz white noise, 300uA amplitude.

  • DeviceHigh-frequency noisy galvanic vestibular stimulation (nGVS)

    Participants received high-frequency noisy galvanic vestibular stimulation through electrodes placed over the bilateral mastoid processes during experimental testing. Stimulation parameters were consistent with the approved study protocol. Frequency was 10-30Hz white noise, 300uA amplitude.

06

What researchers measure

Primary outcomes

  1. Vestibular Direction Recognition Threshold

    Vestibular perceptual sensitivity was assessed using roll-tilt and interaural translation direction recognition tasks performed on a six-degree-of-freedom motion platform. Direction recognition thresholds were estimated from participant responses using an adaptive three-down, one-up staircase procedure and cumulative Gaussian psychometric curve fitting. Lower threshold values indicate greater vestibular sensitivity and improved perception of self-motion.

    Time frame: Day 1 (single study visit): Participants completed outcome assessments during each randomized intervention condition (No nGVS, Low-Frequency nGVS, and High-Frequency nGVS). Each assessment required approximately 5 minutes to complete.

  2. Perceptual Motion Tracking Accuracy

    Perceptual motion tracking performance was evaluated during continuous pseudorandom roll motion. Participants used a joystick to continuously indicate their perceived direction and magnitude of platform motion. Performance was quantified using the root mean square error (RMSE) between joystick responses and the programmed motion stimulus, with lower RMSE values indicating more accurate perception and tracking of self-motion.

    Time frame: Day 1 (single study visit): Participants completed outcome assessments during each randomized intervention condition (No nGVS, Low-Frequency nGVS, and High-Frequency nGVS). Each assessment required approximately 5 minutes to complete.

  3. Manual Control Nulling Accuracy

    Manual control performance was evaluated during continuous pseudorandom roll motion while participants used a joystick to actively minimize platform motion by generating corrective control inputs. Performance was quantified using the root mean square error (RMSE) between the platform tilt angle and the upright position over time. Lower RMSE values indicate more effective manual control and disturbance rejection.

    Time frame: Day 1 (single study visit): Participants completed outcome assessments during each randomized intervention condition (No nGVS, Low-Frequency nGVS, and High-Frequency nGVS). Each assessment required approximately 5 minutes to complete.

Secondary outcomes

  1. Roll-Tilt Vestibular Direction Recognition Threshold

    Vestibular perceptual threshold for roll-tilt motion was measured using a computerized three-down, one-up adaptive staircase procedure during a 1 Hz sinusoidal motion stimulus. Thresholds were estimated by fitting a cumulative Gaussian psychometric function to participants' left/right direction recognition responses. Lower threshold values indicate greater vestibular sensitivity.

    Time frame: Day 1 (single study visit): Participants completed outcome assessments during each randomized intervention condition (No nGVS, Low-Frequency nGVS, and High-Frequency nGVS). Each assessment required approximately 5 minutes to complete.

  2. Interaural Translation Vestibular Direction Recognition Threshold

    Vestibular perceptual threshold for interaural translation motion was measured using a computerized three-down, one-up adaptive staircase procedure during a 1 Hz sinusoidal motion stimulus. Thresholds were estimated by fitting a cumulative Gaussian psychometric function to participants' left/right direction recognition responses. Lower threshold values indicate greater vestibular sensitivity.

    Time frame: Day 1 (single study visit): Participants completed outcome assessments during each randomized intervention condition (No nGVS, Low-Frequency nGVS, and High-Frequency nGVS). Each assessment required approximately 5 minutes to complete.

  3. Vestibular Direction Recognition Bias

    Response bias during the vestibular direction recognition task was estimated from the mean of the cumulative Gaussian psychometric function. Bias represents the stimulus magnitude at which participants were equally likely to perceive motion in either direction, providing a measure of systematic perceptual offset.

    Time frame: Day 1 (single study visit): Participants completed outcome assessments during each randomized intervention condition (No nGVS, Low-Frequency nGVS, and High-Frequency nGVS). Each assessment required approximately 5 minutes to complete.

  4. Perceptual Motion Tracking Variability

    Variability of perceptual motion tracking performance during continuous pseudorandom roll motion. Tracking variability was quantified using statistical measures including standard deviation and variance of tracking performance, providing an assessment of the consistency and precision of participant responses.

    Time frame: Day 1 (single study visit): Participants completed outcome assessments during each randomized intervention condition (No nGVS, Low-Frequency nGVS, and High-Frequency nGVS). Each assessment required approximately 5 minutes to complete.

  5. Manual Control Nulling Variability

    Variability of manual control performance during the nulling task was quantified using standard deviation, variance, and mean absolute deviation of chair tilt relative to the upright position. These measures assessed the consistency and precision of participants' ability to minimize platform motion.

    Time frame: Day 1 (single study visit): Participants completed outcome assessments during each randomized intervention condition (No nGVS, Low-Frequency nGVS, and High-Frequency nGVS). Each assessment required approximately 5 minutes to complete.

07

Study locations

1 site
  • Nasa Jsc B21
    Houston, Texas 77058, United States
08

References and documents

Study documents

  • Informed consent form · Apr 1, 2022

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the results reported in the publication, including vestibular threshold measurements, perceptual motion tracking data, manual control performance data, and associated analysis code, will be made available upon reasonable request to the corresponding author. Additional study documents, including the study protocol, statistical analysis plan, and data dictionary, will also be available to support reproducibility. Data sharing will be subject to applicable institutional policies, IRB requirements, and any NASA data-sharing requirements in effect at the time of the request.

Supporting information: Study protocol, Sap, Analytic code

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 28, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07730398
Lead sponsor
National Aeronautics and Space Administration (NASA)
Responsible party
Sponsor
First posted
Jul 28, 2026
Start date
Feb 19, 2024
Primary completion
Mar 18, 2024
Completion
Mar 18, 2024
Last update
Jul 28, 2026

Study contacts

Scott J Wood, PhD
principal investigator · National Aeronautics and Space Administration (NASA)

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion